http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111499732-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_089d40759d5e23b2760341e8f5fd5ce8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
filingDate 2020-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24d0183f8ac9eda1e6924cf8092d42e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f03fd9f1c52c5e92313f90104fe075b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4ca05845e3165bbb7b070f2c7d7f62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6e2486edb1360733f7a1a175c8ca129
publicationDate 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111499732-A
titleOfInvention A kind of hemoglobin oxygen carrier based on double chemical modification and its preparation method and application
abstract The invention relates to a hemoglobin oxygen carrier based on double chemical modification, a preparation method and application thereof. In the hemoglobin oxygen carrier based on double chemical modification, two Val-1(α) residues are carboxymethylated, and two Lys The -99(α) residue is intramolecularly cross-linked. Two of the Lys-99(α) residues undergo intramolecular cross-linking, and the fumarimide bridge formed can change the electrostatic interaction of adult hemoglobin (HbA) molecules, stabilize the tonic state (T state) of HbA, and reduce its Oxygen affinity; Val-1(α) is located at the αα-terminal of the hole in the HbA center and can participate in the formation of salt bridges that help stabilize the relaxed state (R state) structure. The carboxylation modification will destroy these salt bridges and reduce HbA The stability of the R state makes the quaternary structure of HbA transfer from the R state to the T state, reducing the affinity of HbA for oxygen. The invention organically combines two modification means, improves the stability of HbA tetramer, enhances electrostatic interaction, improves the binding state of oxygen binding region and oxygen, and has strong oxygen carrying/releasing activity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112852772-A
priorityDate 2020-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID751
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409431953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71311527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409092530
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451761003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451919690
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218782
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447816241
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID57667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411161974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20587905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451186576
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396422
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525976
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ42665

Total number of triples: 68.